Explore the categories so you can find more about your search.

Categorie > Arthritis

Cartilage Repair Gel Under Development, Which Will Improve Quality Of Life For People Suffering With Medical Joint Trouble

Categorie : Arthritis
The University of Bradford's School of Engineering, Design and Technology and Advanced Gel Technology Ltd (AGT), a University spin-out company, are developing a cartilage repair gel to improve the quality of life for people suffering with medical joint trouble such as osteoarthritis. ...

read more The University of Bradford's School of Engineering, Design and Technology and Advanced Gel Technology Ltd (AGT), a University spin-out company, are developing a cartilage repair gel to improve the quality of life for people suffering with medical joint trouble such as osteoarthritis. read more Sat Jul 2008 Sat Jul 2008

Patients Taking Cymbalta® Reported Reduced Pain Severity Of Osteoarthritis Of The Knee In New Study

Categorie : Arthritis
New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta (duloxetine HCl) once daily experienced significant pain reduction. Patients taking duloxetine reported significant pain improvement compared to placebo within the first week of treatment that ...

read more New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta (duloxetine HCl) once daily experienced significant pain reduction. Patients taking duloxetine reported significant pain improvement compared to placebo within the first week of treatment that read more Wed Jul 2008 Wed Jul 2008

New Guidelines For Treating Rheumatoid Arthritis

Categorie : Arthritis
Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (U ...

read more Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (U read more Wed Jul 2008 Wed Jul 2008

Roche Comment On NICE Anti-TNF Inhibitor Sequencing FAD

Categorie : Arthritis
Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they will continue to benefit from access to effective treatment with MabThera (rituximab ...

read more Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they will continue to benefit from access to effective treatment with MabThera (rituximab read more Wed Jul 2008 Wed Jul 2008

Study Showed Half Of Patients Treated With Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission

Categorie : Arthritis
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Amgen (NASDAQ:AMGN) announced the publication of data from the COMET (COmbination of Methotrexate and ETanercept in Active Early Rheumatoid Arthritis) trial demonstrating that half of patients treated with the combination of ENBREL and meth ...

read more Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Amgen (NASDAQ:AMGN) announced the publication of data from the COMET (COmbination of Methotrexate and ETanercept in Active Early Rheumatoid Arthritis) trial demonstrating that half of patients treated with the combination of ENBREL and meth read more Wed Jul 2008 Wed Jul 2008

Improved Rheumatoid Arthritis Remission With Combined Therapy

Categorie : Arthritis
For patients with active, early stage, moderate-to-severe rheumatoid arthritis, a combination treatment with methotrexate and etanercept can improve remission and radiographic non-progression rates within one year in comparison with just methotrexate. Additionally, more patients are also able ...

read more For patients with active, early stage, moderate-to-severe rheumatoid arthritis, a combination treatment with methotrexate and etanercept can improve remission and radiographic non-progression rates within one year in comparison with just methotrexate. Additionally, more patients are also able read more Wed Jul 2008 Wed Jul 2008

Custom-Made Insoles Offer Relief To Sufferers Of Foot Pain

Categorie : Arthritis
Custom-made insoles known as foot orthoses can reduce foot pain caused by arthritis, overly prominent big toe joints and highly arched feet, a new systematic review shows. A team of Cochrane Researchers found that custom orthoses were safe interventions for foot pain in a number of different cond ...

read more Custom-made insoles known as foot orthoses can reduce foot pain caused by arthritis, overly prominent big toe joints and highly arched feet, a new systematic review shows. A team of Cochrane Researchers found that custom orthoses were safe interventions for foot pain in a number of different cond read more Wed Jul 2008 Wed Jul 2008

Greater Relief From Osteoarthritis Symptoms Found In Joint Replacement Surgery

Categorie : Arthritis
The long term health outcomes of hip or knee replacement surgery in older adults are excellent despite taking several weeks to recover, according to a report released on July 14, 2008 in the Archives of Internal Medicine, one of the JAMA/Archives journals. Osteoarthritis is a degenerative joint d ...

read more The long term health outcomes of hip or knee replacement surgery in older adults are excellent despite taking several weeks to recover, according to a report released on July 14, 2008 in the Archives of Internal Medicine, one of the JAMA/Archives journals. Osteoarthritis is a degenerative joint d read more Wed Jul 2008 Wed Jul 2008

New Survey Findings Reveal Emotional And Physical Toll Of Rheumatoid Arthritis And The Advancement Of Treatment Through "Generations"

Categorie : Arthritis
Emotional and physical limitations are significant challenges cited by people diagnosed with rheumatoid arthritis (RA), according to the results released from two new, groundbreaking parallel surveys. ...

read more Emotional and physical limitations are significant challenges cited by people diagnosed with rheumatoid arthritis (RA), according to the results released from two new, groundbreaking parallel surveys. read more Wed Jul 2008 Wed Jul 2008

Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study For Gout

Categorie : Arthritis
Ardea Biosciences, Inc. (Nasdaq: RDEA) announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patients with hyperuricemia. Gout, also known as metabolic arthritis, is a painful and debilitating disease caused by abnor ...

read more Ardea Biosciences, Inc. (Nasdaq: RDEA) announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patients with hyperuricemia. Gout, also known as metabolic arthritis, is a painful and debilitating disease caused by abnor read more Tue Jul 2008 Tue Jul 2008

Tilapia Contains Potentially Dangerous Fatty Acid Combination

Categorie : Arthritis
Farm-raised tilapia, one of the most highly consumed fish in America, has very low levels of beneficial omega-3 fatty acids and, perhaps worse, very high levels of omega-6 fatty acids, according to new research from Wake Forest University School of Medicine. ...

read more Farm-raised tilapia, one of the most highly consumed fish in America, has very low levels of beneficial omega-3 fatty acids and, perhaps worse, very high levels of omega-6 fatty acids, according to new research from Wake Forest University School of Medicine. read more Tue Jul 2008 Tue Jul 2008

Who Cares Wins: Medical Journalists Vote Arthritis Care Health Charity Of The Year, UK

Categorie : Arthritis
The UK's leading organisation supporting and representing the interests of people with any of the 200 forms of arthritis was last night voted Health Charity of the Year by members of the Medical Journalists' Association. The user-led charity, which celebrated its diamond jubilee in 2007 and pre- ...

read more The UK's leading organisation supporting and representing the interests of people with any of the 200 forms of arthritis was last night voted Health Charity of the Year by members of the Medical Journalists' Association. The user-led charity, which celebrated its diamond jubilee in 2007 and pre- read more Sat Jul 2008 Sat Jul 2008

Phase II Results For Low-Dose Oral Immune Tolerance Therapy (ARG201) In Systemic Scleroderma Published

Categorie : Arthritis
arGentis Pharmaceuticals, LLC announced that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-revi ...

read more arGentis Pharmaceuticals, LLC announced that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-revi read more Sat Jul 2008 Sat Jul 2008

Highlights From EULAR 2008, The Annual European Congress Of Rheumatology

Categorie : Arthritis
Half of patients with early rheumatoid arthritis treated with the anti-tumour necrosis factor inhibitor (anti-TNF) infliximab plus methotrexate achieve remission, and up to one in five achieve drug-free remission, according to five-year follow-up results from the BeSt study. Patients treated ini ...

read more Half of patients with early rheumatoid arthritis treated with the anti-tumour necrosis factor inhibitor (anti-TNF) infliximab plus methotrexate achieve remission, and up to one in five achieve drug-free remission, according to five-year follow-up results from the BeSt study. Patients treated ini read more Sat Jul 2008 Sat Jul 2008

New Book For Parents Of Children With Juvenile Arthritis

Categorie : Arthritis
The Arthritis Foundation announces the publication of a new book for parents of children with juvenile arthritis (JA). Released in conjunction with Juvenile Arthritis Awareness Month in July, the all-new Raising a Child with Arthritis addresses many of the concerns parents have about JA - from ...

read more The Arthritis Foundation announces the publication of a new book for parents of children with juvenile arthritis (JA). Released in conjunction with Juvenile Arthritis Awareness Month in July, the all-new Raising a Child with Arthritis addresses many of the concerns parents have about JA - from read more Sat Jul 2008 Sat Jul 2008

Pediatric Researchers Find Possible 'Master Switch' Gene In Juvenile Arthritis

Categorie : Arthritis
Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a "master switch" that helps turn on the debilitating disease. Researc ...

read more Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a read more Wed Jul 2008 Wed Jul 2008

Cimzia(R) Filed With EMEA For Treatment Of Rheumatoid Arthritis, Europe

Categorie : Arthritis
UCB announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of Cimzia® (certolizumab pegol) as a subcutaneous treatment for adults with moderate to severe active rheumatoid arthritis (RA) and has been accepted for ...

read more UCB announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of Cimzia® (certolizumab pegol) as a subcutaneous treatment for adults with moderate to severe active rheumatoid arthritis (RA) and has been accepted for read more Wed Jul 2008 Wed Jul 2008

Increased Risk Of Developing Rheumatoid Arthritis When Birth Weight Exceeds 10 Pounds

Categorie : Arthritis
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of ...

read more People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of read more Wed Jul 2008 Wed Jul 2008

Study Reveals Potential For NT-proBNP As A Marker To Predict Cardiovascular Risks From Anti-inflammatory Drugs

Categorie : Arthritis
Roche has announced the results of a pilot study evaluating the use of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting the risk of cardiovascular adverse events (CV-AE) in patients treated with non-steroidal anti-inflammatory drugs of the COX inhibitor class. Non-steroidal ant ...

read more Roche has announced the results of a pilot study evaluating the use of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting the risk of cardiovascular adverse events (CV-AE) in patients treated with non-steroidal anti-inflammatory drugs of the COX inhibitor class. Non-steroidal ant read more Wed Jul 2008 Wed Jul 2008

Females With High Birth Weight More Likely To Develop Rheumatoid Arthritis

Categorie : Arthritis
A new study published in the Annals of the Rheumatic Diseases finds that compared to females born with average birth weight, those born with heavy birth weight are two times as likely to develop rheumatoid arthritis when they become adults. Rheumatoid arthritis is a condition that occurs when ...

read more A new study published in the Annals of the Rheumatic Diseases finds that compared to females born with average birth weight, those born with heavy birth weight are two times as likely to develop rheumatoid arthritis when they become adults. Rheumatoid arthritis is a condition that occurs when read more Wed Jul 2008 Wed Jul 2008

1 | 2 | 3 | 4 next >>>



     


Custom Search